REQUEST A DEMO
Total
USD $0.00
Search more companies

Lu Scientific D.O.O. Beograd-savski Venac (Serbia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Lu Scientific D.O.O. Beograd-savski Venac Profile Updated: October 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Lu Scientific D.O.O. Beograd-savski Venac is a company in Serbia, with a head office in Belgrade. The enterprise currently operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. Lu Scientific D.O.O. Beograd-savski Venac was incorporated on April 01, 2016. The company’s latest financial report indicates a net sales revenue drop of 58.69% in 2023. There was a total growth of 25.94% in Lu Scientific D.O.O. Beograd-savski Venac’s total assets over the same period. In 2023, Lu Scientific D.O.O. Beograd-savski Venac’s net profit margin increased by 14.98%.

Headquarters
Kneza Milosa 93
Belgrade; Belgrade;

Contact Details: Purchase the Lu Scientific D.O.O. Beograd-savski Venac report to view the information.

Website: http://CUBE_PROFILES_YU

Basic Information
Outstanding Shares:
Purchase the Lu Scientific D.O.O. Beograd-savski Venac report to view the information.
Registered Capital:
Purchase the Lu Scientific D.O.O. Beograd-savski Venac report to view the information.
Incorporation Date:
April 01, 2016
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Quatalia D.O.O.
30%
Company Performance
Financial values in the chart are available after Lu Scientific D.O.O. Beograd-savski Venac report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RSD. Absolute financial data is included in the purchased report.
Net sales revenue
-58.69%
Total operating revenue
-58.55%
Operating profit (EBIT)
-72.59%
Net Profit (Loss) for the Period
64.09%
Total assets
25.94%
Total equity
46.98%
Operating Profit Margin (ROS)
-1%
Net Profit Margin
14.98%
Return on Equity (ROE)
3.33%
Quick Ratio
11.05%
Cash Ratio
10.28%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?